RELATIONAL ARCHITECTS INTERNATIONAL
Relational Architects International is the software products firm.
RELATIONAL ARCHITECTS INTERNATIONAL
Industry:
Consulting Professional Services Software
Address:
Hoboken, New Jersey, United States
Country:
United States
Website Url:
http://www.relarc.com
Status:
Active
Contact:
201 420-0400
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Apache 2.4 OpenSSL CPanel CentOS GlobalSign Liquid Web
Similar Organizations
Acretix
Acretix is a is a business operations software platform.
Conservation Resource Solutions
Conservation Resource Solutions is a software company.
Official Site Inspections
http://www.relarc.com Semrush global rank: 7.28 M Semrush visits lastest month: 104
- Host name: ec2-50-112-202-115.us-west-2.compute.amazonaws.com
- IP address: 50.112.202.115
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Relational Architects International"
Extended Lymph Node Dissection for Right-Sided Colon …
Oct 30, 2024 · The RELARC trial found that complete mesocolic excision (CME) for people undergoing laparoscopic colectomy for right-sided colon cancer did not improve disease-free …See details»
Extent of Lymphadenectomy for Surgical Management of …
Aug 27, 2024 · Complete mesocolic excision (CME) is being increasingly used for the treatment of right-sided colon cancer, although there is still no strong evidence that CME provides better …See details»
ReLARC
ReLARC (Reversible Long-Acting Reproductive Control) is a new hysteroscopic technique for the insertion of long-term contraceptive devices. The procedure is conducted under direct …See details»
Laparoscopic complete mesocolic excision: safe …
Feb 12, 2021 · Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic right colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialSee details»
Complete mesocolic excision for right hemicolectomy: an …
Aug 26, 2023 · Complete mesocolic excision improves lymphadenectomy for right hemicolectomy and respects the embryological planes. However, its effect on cancer-free and overall survival …See details»
Complete Mesocolic Excision is a Safe Option in …
Apr 7, 2021 · Early safety data from the RELARC trial showed complete mesocolic excision doesn’t increase intraoperative and postoperative complications of laparoscopic right …See details»
Short-term outcomes of complete mesocolic excision …
Background Whether extended lymphadenectomy for right colon cancer leads to increased perioperative complications or improves survival is still controversial. This trial aimed to …See details»
The Radical Extent of lymphadenectomy - BioMed Central
Dec 8, 2016 · The RELARC trial is a prospective, multicenter, randomized controlled trial that will provide evidence on the optimal extent of lymphadenectomy during laparoscopic right …See details»
Short-term outcomes of complete mesocolic excision …
Feb 12, 2021 · Complete mesocolic excision for right-sided colon cancer is safe without increasing complications or hospital stay, with an acceptable increase in operative time, and a …See details»
Complete mesocolic excision for colon cancer: …
Oct 18, 2023 · Meticulous anatomical dissection along embryonic planes is a well-established principle of precision cancer surgery used routinely by the specialist colorectal surgeon.See details»
Short-Term Outcomes of Complete Mesocolic Excision …
Oct 23, 2020 · Short-Term Outcomes of Complete Mesocolic Excision Versus D2 Dissection in Patients Undergoing Laparoscopic Colectomy for Right Colon Cancer (RELARC Trial): A …See details»
Complete mesocolic excision and D3 lymphadenectomy …
May 11, 2021 · In right-sided colon cancer surgery, currently there is a great deal of discussion and debate regarding complete mesocolic excision (CME) versus conventional right …See details»
A Randomized Phase III Trial of Complete Mesocolic …
The RELARC study is a multicenter, high-volume, phase 3 superiority trial from China, whereas the Agrusa study is a single-center low-volume trial from Italy. 17,18 After the analysis of early …See details»
Short-term outcomes of complete mesocolic excision …
Mar 1, 2021 · Owing to the complexity of right hemicolectomy and the precise advantages of laparoscopic technology in colon cancer, this study used a randomised, controlled trial design …See details»
Intracorporeal Anastomosis Versus Extracorporeal …
Jan 12, 2023 · Briefly, the RELARC trial was a national multicenter randomized controlled trial comparing D2 lymph node dissection versus complete mesocolic excision (CME) in …See details»
Right-Sided Colon Cancer: Complete Mesocolic Excision …
Sep 12, 2024 · As reported in Journal of Clinical Oncology by Lu et al, the Chinese phase III RELARC trial showed no significant improvement in disease-free survival with complete …See details»
Meeting Abstract: 2024 ASCO Annual Meeting I - ASCO …
May 29, 2024 · Background: Complete mesocolic excision (CME) is being increasingly used for the treatment of right-sided colon cancer although there is still no strong evidence that CME …See details»
Comparison of D2 vs D3 lymph node dissection for RIght …
Jul 2, 2024 · Currently, the RELARC trial has investigated long-term outcomes (primary endpoint being 3-year disease-free survival) for right colon cancer, although the gold standard for …See details»
Short-term outcomes of complete mesocolic excision …
Feb 12, 2021 · Whether extended lymphadenectomy for right colon cancer leads to increased perioperative complications or improves survival is still controversial. This trial aimed to …See details»
The Radical Extent of lymphadenectomy - Semantic Scholar
Dec 8, 2016 · The RELARC trial is a prospective, multicenter, randomized controlled trial that will provide evidence on the optimal extent of lymphadenectomy during laparoscopic right …See details»